Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single case

被引:39
作者
Chiecchio, Laura [1 ]
Dagrada, Gian Paolo [1 ]
Protheroe, Rebecca K. M. [1 ]
Stockley, David M. [1 ]
Smith, Alastair G. [2 ]
Orchard, Kim H. [2 ,3 ]
Cross, Nicholas C. P. [1 ]
Harrison, Christine J. [4 ]
Ross, Fiona M. [1 ]
机构
[1] Univ Southampton, Div Human Genet, Wessex Reg Genet Lab,Salisbury Dist Hosp, Leukaemia Res Fund UK,Myeloma Forum Cytogenet Grp, Salisbury, Wilts, England
[2] Southampton Univ Hosp NHS Trust, Southampton Gen Hosp, Dept Haematol, Southampton, Hants, England
[3] Univ Southampton, Canc Sci Div, Southampton, Hants, England
[4] Univ Newcastle, No Inst Canc Res, Leukaemia Res Cytogenet Grp, Newcastle Upon Tyne, Tyne & Wear, England
来源
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷 / 07期
关键词
smouldering multiple myeloma; plasma cell; chromosomal abnormality; progression; arrayCGH; ASYMPTOMATIC MULTIPLE-MYELOMA; UNDETERMINED SIGNIFICANCE; MONOCLONAL GAMMOPATHY; PROGNOSTIC-FACTOR; NATURAL-HISTORY; ABNORMALITIES; HYBRIDIZATION; FEATURES;
D O I
10.3324/haematol.2008.004440
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report serial genetic studies on a young female patient initially diagnosed with asymptomatic smouldering myeloma who progressed to symptomatic myeloma 4.5 years after presentation. An unbalanced translocation, der(14)t(4;14)(p16;q32), was initially found in all plasma cells plus deletions of other chromosomal regions as detected by array-based comparative genomic hybridization. Deletion of chromosome 13 was observed in a minor population of plasma cells (<20%) for the first two years, increasing to 100% of plasma cells by the time of multiple myeloma diagnosis. Loss of 1p and a rearrangement of MYC were first observed in a small population of plasma cells one year prior to the clinical diagnosis of multiple myeloma, but these subclones increased rapidly in size to become the major population suggesting that they were directly involved in the transformation process. This case report provides a unique insight into the mechanisms of disease progression from smouldering multiple myeloma to multiple myeloma.
引用
收藏
页码:1024 / 1028
页数:5
相关论文
共 24 条
[1]   Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation [J].
Avet-Loiseau, H ;
Facon, T ;
Grosbois, B ;
Magrangeas, F ;
Rapp, MJ ;
Harousseau, JL ;
Minvielle, S ;
Bataille, R .
BLOOD, 2002, 99 (06) :2185-2191
[2]   Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors [J].
Avet-Loiseau, H ;
Gerson, F ;
Magrangeas, F ;
Minvielle, S ;
Harousseau, JL ;
Bataille, R .
BLOOD, 2001, 98 (10) :3082-3086
[3]   Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome [J].
Avet-Loiseau, Herve ;
Attal, Michel ;
Moreau, Philippe ;
Charbonnel, Catherine ;
Garban, Frederic ;
Hulin, Cyrille ;
Leyvraz, Serge ;
Michallet, Mauricette ;
Yakoub-Agha, Ibrahim ;
Garderet, Laurent ;
Marit, Gerald ;
Michaux, Lucienne ;
Voillat, Laurent ;
Renaud, Marc ;
Grosbois, Bernard ;
Guillerm, Gaelle ;
Benboubker, Lotfi ;
Monconduit, Mathieu ;
Thieblemont, Catherine ;
Casassus, Philippe ;
Caillot, Denis ;
Stoppa, Anne-Marie ;
Sotto, Jean-Jacques ;
Wetterwald, Marc ;
Dumontet, Charles ;
Fuzibet, Jean-Gabriel ;
Azais, Isabelle ;
Dorvaux, Veronique ;
Zandecki, Marc ;
Bataille, Regis ;
Minvielle, Stephane ;
Harousseau, Jean-Luc ;
Facon, Thierry ;
Mathiot, Claire .
BLOOD, 2007, 109 (08) :3489-3495
[4]   Molecular pathogenesis and a consequent classification of multiple myeloma [J].
Bergsagel, PL ;
Kuehl, WM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (26) :6333-6338
[5]   Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma [J].
Bergsagel, PL ;
Kuehl, WM ;
Zhan, FH ;
Sawyer, J ;
Barlogie, B ;
Shaughnessy, J .
BLOOD, 2005, 106 (01) :296-303
[6]   Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma [J].
Chiecchio, L. ;
Protheroe, R. K. M. ;
Ibrahim, A. H. ;
Cheung, K. L. ;
Rudduck, C. ;
Dagrada, G. P. ;
Cabanas, E. D. ;
Parker, T. ;
Nightingale, M. ;
Wechalekar, A. ;
Orchard, K. H. ;
Harrison, C. J. ;
Cross, N. C. P. ;
Morgan, G. J. ;
Ross, F. M. .
LEUKEMIA, 2006, 20 (09) :1610-1617
[7]   Paradoxical expression of INK4c in proliferative multiple myeloma tumors: bi-allelic deletion vs increased expression [J].
Dib, Amel ;
Peterson, Timothy R. ;
Raducha-Grace, Laura ;
Zingone, Adriana ;
Zhan, Fenghuang ;
Hanamura, Ichiro ;
Barlogie, Bart ;
Shaughnessy, John, Jr. ;
Kuehl, W. Michael .
CELL DIVISION, 2006, 1 (1)
[8]   Clinical and biologic implications of recurrent genomic aberrations in myeloma [J].
Fonseca, R ;
Blood, E ;
Rue, M ;
Harrington, D ;
Oken, MM ;
Kyle, RA ;
Dewald, GW ;
Van Ness, B ;
Van Wier, SA ;
Henderson, KJ ;
Bailey, RJ ;
Greipp, PR .
BLOOD, 2003, 101 (11) :4569-4575
[9]   Genomic abnormalities in monoclonal gammopathy of undetermined significance [J].
Fonseca, R ;
Bailey, RJ ;
Ahmann, GJ ;
Rajkumar, SV ;
Hoyer, JD ;
Lust, JA ;
Kyle, RA ;
Gertz, MA ;
Greipp, PR ;
Dewald, GW .
BLOOD, 2002, 100 (04) :1417-1424
[10]  
Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876